MedPath

Oxybutynin Chloride

Oxybutynin Chloride Tablets, USP Rx only

Approved
Approval ID

3418ca19-feb0-9821-e063-6394a90ae819

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 1, 2025

Manufacturers
FDA

AvKARE

DUNS: 796560394

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Oxybutynin Chloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42291-456
Application NumberANDA208165
Product Classification
M
Marketing Category
C73584
G
Generic Name
Oxybutynin Chloride
Product Specifications
Route of AdministrationORAL
Effective DateMay 1, 2025
FDA Product Classification

INGREDIENTS (5)

FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
STARCH, PREGELATINIZED CORNInactive
Code: O8232NY3SJ
Classification: IACT
OXYBUTYNIN CHLORIDEActive
Quantity: 5 mg in 1 1
Code: L9F3D9RENQ
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Oxybutynin Chloride - FDA Drug Approval Details